NinePointTwo Capital »

Amicus Therapeutics shares owned by NinePointTwo Capital

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by NinePointTwo Capital from 13F filings

Historical chart of NinePointTwo Capital investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by NinePointTwo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by NinePointTwo Capital

Quarter filed Position value Share count Share price at filing
2023-06-30 $251k 20k 12.55
2023-03-31 $221k 20k 11.05
2022-12-31 $252k 21k 12.20

More positions owned by NinePointTwo Capital

Schwab Strategic Tr Us Tips Etf (SCHP)
Vaneck Etf Trust Jp Mrgan Em Loc (EMLC)
Ishares Tr Tips Bd Etf (TIP)
Dbx Etf Tr Xtrack Usd High (HYLB)
Vanguard Whitehall Fds High Div Yld (VYM)
Invesco Actvely Mngd Etc Optimum Yield (PDBC)
Ishares Tr Select Divid Etf (DVY)
Apollo Global Mgmt (APO)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Apple (AAPL)
Hca Holdings (HCA)
Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Meta Platforms Cl A (META)
Nxp Semiconductors N V (NXPI)

View all positions for NinePointTwo Capital

Top funds holding Amicus Therapeutics

Vanguard Group
Wellington Management Company
BlackRock
William Blair Investment Management
venBio Select Advisor
Millennium Management
State Street Corporation
Vestal Point Capital
Citadel Advisors
Point72 Asset Management
Geode Capital Management
Pictet Asset Management Holding SA
Perceptive Advisors
Palo Alto Investors
Soleus Capital Management

View all funds holding Amicus Therapeutics